Get the Stockscreener App
8.3662
0.68%
0.0562
After Hours:
8.37
0.0038
+0.05%
Pharming Group N V Adr stock is traded at $8.3662, with a volume of 2,147.
It is up +0.68% in the last 24 hours and down -3.62% over the past month.
See More
Previous Close:
$8.31
Open:
$8.45
24h Volume:
2,147
Relative Volume:
0.35
Market Cap:
$586.78M
Revenue:
$277.56M
Net Income/Loss:
$-13.33M
P/E Ratio:
-44.03
EPS:
-0.19
Net Cash Flow:
$-6.54M
1W Performance:
-5.29%
1M Performance:
-3.62%
6M Performance:
+1.41%
1Y Performance:
-22.82%
1-Day Range:
$8.10
$8.59
1-Week Range:
$8.03
$8.85
52-Week Range:
$6.65
$11.30
Pharming Group N V Adr Stock (PHAR) Company Profile
Compare PHAR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PHAR
Pharming Group N V Adr
|
8.3662 | 586.78M | 277.56M | -13.33M | -6.54M | -0.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.82 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.23 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
591.87 | 36.10B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
270.02 | 35.03B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
272.17 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Pharming Group N V Adr Stock (PHAR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-24 | Initiated | Jefferies | Buy |
Pharming Group N V Adr Stock (PHAR) Latest News
Pharming Group to participate in March investor conference - GlobeNewswire Inc.
Pharming Group (OTCMKTS:PHGUF) Shares Cross Above 50 Day Moving Average – Time to Sell? - Defense World
Pharming Group N.V. (AMS:PHARM) Held Back By Insufficient Growth Even After Shares Climb 26% - Simply Wall St
Pharming Group stock gains on KL1333’s blockbuster potential, says RBC - Investing.com India
H.C. Wainwright reiterates Buy on Pharming stock, pediatric trial shows safety and tolerability - Investing.com India
Jefferies initiates Pharming Group shares with Buy on revenue growth - Investing.com India
Oppenheimer cuts Pharming Group stock target, Outperform on Q3 results - Investing.com India
Earnings call: Pharming Group NV reports growth amid CEO transition - Investing.com
Earnings call: Pharming Group NV sees robust growth in Q3, CEO to step down - Investing.com
October 2024's Promising Penny Stocks to Watch - Yahoo Finance
Novavax (NVAX) Moves 19.2% Higher: Will This Strength Last? - Yahoo Finance
Earnings call: Pharming Group reports robust growth and pipeline expansion - Investing.com
RGC Stock Quote Price and Forecast - CNN
Why Earnings Season Could Be Great for Pharming Group (PHAR) - Yahoo Finance
Can Pharming Group N.V. Sponsored ADR (PHAR) Run Higher on Rising Earnings Estimates? - Yahoo Finance
Pharming Group (PHAR) - Zacks Investment Research
PHARM Stock Price and Chart — EURONEXT:PHARM - TradingView
Pharming Group N V Adr Stock (PHAR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.05%
1.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):